These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2971077)

  • 1. Reduced urinary kallikrein in hypertensive diabetic patients.
    Marre M; Alhenc-Gelas F; Menard J; Passa P
    J Diabet Complications; 1988; 2(2):88-91. PubMed ID: 2971077
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal kallikrein in diabetic patients with hypertension accompanied by nephropathy.
    Baba T; Murabayashi S; Ishizaki T; Ido Y; Aoyagi K; Takebe K
    Diabetologia; 1986 Mar; 29(3):162-7. PubMed ID: 3516773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal kallikrein in human and experimental diabetes mellitus.
    Mayfield RK; Margolius HS; Shimojo N; Miller DH; Squires J; Namm DH
    Horm Metab Res Suppl; 1985; 15():31-7. PubMed ID: 3865881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal kallikrein in diabetic nephropathy].
    Pérez Blanco FJ; Cuesta López MJ; Fernández García C; Saucedo Sánchez R; Rodríguez Cuartero A
    Rev Clin Esp; 1991 Feb; 188(3):123-6. PubMed ID: 1780509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kallikrein-kinin system in early state of diabetes.
    Vila SB; Peluffo VA; Alvarado C; Cresto JC; Zuccollo A; Catanzaro OL
    Agents Actions Suppl; 1992; 38 ( Pt 3)():304-10. PubMed ID: 1462865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered urinary excretion of human kininase activity in hypertension.
    Greco A; Porcelli G; Di Jorio M; Ranieri M; D'Acguarica L; Ranalli L
    Adv Exp Med Biol; 1979; 120B():645-9. PubMed ID: 517258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary kallikrein excretion in type 1 (insulin-dependent) diabetes mellitus.
    Manto A; Cotroneo P; Porcelli G; D'Errico G; Marra G; Magnani P; Tilli P; Greco AV; Ghirlanda G
    Diabetologia; 1993 May; 36(5):423-7. PubMed ID: 8314446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral potassium on urinary kallikrein excretion in essential hypertension.
    Murakami E; Hiwada K; Kokubu T; Imamura Y
    Adv Exp Med Biol; 1989; 247B():133-7. PubMed ID: 2610052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cholinesterase activity in diabetes and associated pathologies.
    Inácio Lunkes G; Stefanello F; Sausen Lunkes D; Maria Morsch V; Schetinger MR; Gonçalves JF
    Diabetes Res Clin Pract; 2006 Apr; 72(1):28-32. PubMed ID: 16233931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():247s-250s. PubMed ID: 396074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of two different assays for urinary kallikrein in normotensive and hypertensive subjects.
    Maier M; Jerabek I; Reissert G; Höltzl E; Binder BR
    Clin Chim Acta; 1988 Dec; 178(2):127-39. PubMed ID: 3242981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary kallikrein excretion in spontaneously hypertensive rats.
    Geller RG; Margolius HS; Pisano JJ; Keiser HR
    Circ Res; 1975 Jun; 36(6 Suppl 1):103-6. PubMed ID: 1132073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary prostaglandins and kallikrein in essential hypertension.
    Weber PC; Scherer B; Held E; Siess W; Stoffel H
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():259s-261s. PubMed ID: 396075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diabetic nephropathy and the development of hypertension in rats.
    Zuccollo A; Navarro M; Catanzaro O
    Int J Exp Diabetes Res; 2001; 2(3):195-9. PubMed ID: 12369707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension and urinary kallikrein].
    Greco AV; Porcelli G; Croxatio HR; Fedeli G; Ghirlanda G
    Minerva Med; 1974 Aug; 65(58):3058-62. PubMed ID: 4848079
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between neuropathy, hypertension and red blood cell Na/K ATPase in patients with insulin-dependent diabetes mellitus.
    Jannot MF; Raccah D; Dufayet de la Tour D; Coste T; Gouvernet J; Vague P
    Diabetes Metab; 1999 Mar; 25(1):35-42. PubMed ID: 10335422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.
    Margolius HS; Horwitz D; Pisano JJ; Keiser HR
    Circ Res; 1974 Dec; 35(6):820-5. PubMed ID: 4430079
    [No Abstract]   [Full Text] [Related]  

  • 18. The kallikrein-kinin pathways in hypertension and diabetes.
    Sharma JN; Narayanan P
    Prog Drug Res; 2014; 69():15-36. PubMed ID: 25130038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism.
    Lechi A; Covi G; Lechi C; Corgnati A; Arosio E; Zatti M; Scuro LA
    Clin Sci Mol Med; 1978 Jul; 55(1):51-5. PubMed ID: 668267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The method of urinary total kallikrein and prekallikrein measurement, and their urinary excretions in the patients with essential hypertension.
    Tanaka S; Shimamoto K; Ura N; Nishitani T; Hosoda S; Ishida H; Yokoyama T; Maeda T; Masuda A; Yamaguchi Y
    Adv Exp Med Biol; 1986; 198 Pt B():343-50. PubMed ID: 3643731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.